Advertisement

AAPS PharmSciTech

, Volume 19, Issue 5, pp 2237–2246 | Cite as

Characterization and In Vitro Permeation Study of Cubic Liquid Crystal Containing Sinomenine Hydrochloride

  • Xiaoqin Chu
  • Qian Li
  • Shuangying Gui
  • Zhengguang Li
  • Jiaojiao Cao
  • Jianqin Jiang
Research Article
  • 110 Downloads

Abstract

This study developed a new transdermal delivery system for the improved delivery of sinomenine hydrochloride (SH). The delivery system utilized the advantages of lyotropic liquid crystals (LLC) creating an adaptable system that offers a variety of options for the field of transdermal delivery. The formulation was prepared, characterized, and evaluated for its skin penetration in vitro. In the study, the appearance of samples was characterized by visual observation, and these LLC gels were colorless and transparent. Polarizing light microscopy (PLM) and small-angle X-ray diffraction (SAXS) were used to analyze the internal structures of gels, and the gels displayed a cubic double-diamond (Pn3m) internal structure with a dark field of vision. The Franze diffusion cell was used to evaluate its skin penetration. There were several factors which might influence the skin penetration of drugs, such as drug loading, water content, and the layer spacing of the LLC. In our case, drug concentration gradient played a more powerful role. The result of in vitro permeation studies demonstrated that the drug concentration was higher; the cumulative osmotic quantity of SH (Q) was greater. Therefore, the system was a promising formulation for successful percutaneous delivery of SH through the skin.

KEY WORDS

sinomenine hydrochloride lyotropic liquid crystals transdermal drug delivery systems skin penetration 

Notes

Acknowledgements

The content is solely the responsibility of the authors and does not necessarily represent the official views of China Pharmaceutical University.

Funding Information

The authors are grateful for financial support from the National Natural Science Foundations of China (No. 81274099, No. 81072537), the Anhui Provincial Natural Science Foundation (No. 1408085QH183), Key University natural science research project of Anhui province (KJ2018A0301), and the Exploratory Research Projects of Anhui University of Chinese Medicine (No. 2016ts066).

Compliance with Ethical Standards

Conflict of Interest

The authors declare that there is no conflict of interest.

References

  1. 1.
    Li X, Li P, Liu C, et al. Sinomenine hydrochloride inhibits breast cancer metastasis by attenuating inflammation-related epithelial-mesenchymal transition and cancer stemness. Oncotarget. 2017;8(8):13560–74.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Sun Y, Yao Y, Ding CZ. A combination of sinomenine and methotrexate reduces joint damage of collagen induced arthritis in rats by modulating osteoclast-related cytokines. Int Immunopharmacol. 2014;18:135–41.CrossRefPubMedGoogle Scholar
  3. 3.
    Qian L, Xu Z, Zhang W, et al. Sinomenine, a natural dextrorotatory morphinan analog, is anti-inflammatory and neuroprotective through inhibition of microglial NADPH oxidase. J Neuroinflammation. 2007;4(1):1–14.CrossRefGoogle Scholar
  4. 4.
    Zhao Y, Li J, Yu K, et al. Sinomenine inhibits maturation of monocyte-derived dendritic cells through blocking activation of NF-kappa B. Int Immunopharmacol. 2007;7(5):637–45.CrossRefPubMedGoogle Scholar
  5. 5.
    Gao T, Hao J, Wiesenfeld-Hallin Z, et al. Analgesic effect of sinomenine in rodents after inflammation and nerve injury. Eur J Pharmacol. 2013;721:5–11.CrossRefPubMedGoogle Scholar
  6. 6.
    Zhou H, Wong YF, Wang J, Cai X, Liu L. Sinomenine ameliorates arthritis via MMPs,TIMPs, and cytokines in rats. Biochem Biophys Res Commun. 2008;376:352–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Zhang MF, Zhao Y, Jiang KY, et al. Comparative pharmacokinetics study of sinomenine in rats after oral administration of sinomenine monomer and Sinomenium acutum extract. Molecules. 2014;19(8):12065–77.CrossRefPubMedGoogle Scholar
  8. 8.
    Li L, Buchet R, Wu Y. Sinomenine, theophylline, cysteine, and levamisole: Comparisons of their kinetic effects on mineral formation induced by matrix vesicles. J Inorg Biochem. 2010;104:446–54.CrossRefPubMedGoogle Scholar
  9. 9.
    Zhao Z, Xiao J, Wang J, et al. Anti-inflammatory effects of novel sinomenine derivatives. Int Immunopharmacol. 2015;29(2):354–60.CrossRefPubMedGoogle Scholar
  10. 10.
    Wu X, Chen Y, Gui S, et al. Sinomenine hydrochloride-loaded dissolving microneedles enhanced its absorption in rabbits. Pharm Dev Technol. 2015;21(7):787–93.PubMedGoogle Scholar
  11. 11.
    Teng P, Liu HL, Zhang L, et al. Synthesis and biological evaluation of novel sinomenine derivatives as anti-inflammatory agents. Eur J Med Chem. 2012;50:63–74.CrossRefPubMedGoogle Scholar
  12. 12.
    Long H, Liu Y, Chen D, et al. Evolution and prospect of Zheng Qingfeng Tong Ning injection. Central South Pharm. 2012;10(4):303–6.Google Scholar
  13. 13.
    Li X, Li X, Zhou Y, et al. Development of patch and spray formulations for enhancing topical delivery of sinomenine hydrochloride. J Pharmaceut Sci. 2010;99(4):1790–9.CrossRefGoogle Scholar
  14. 14.
    Langer R. Transdermal drug delivery: past progress, current status, and future prospects. Adv Drug Deliv Rev. 2004;56(5):557–8.CrossRefPubMedGoogle Scholar
  15. 15.
    Thomas BJ, Finnin BC. The transdermal revolution. Drug Discov Today. 2004;9(16):697.CrossRefPubMedGoogle Scholar
  16. 16.
    Kadhum WR, Sekiguchi S, Hijikuro I, et al. A novel chemical enhancer approach for transdermal drug delivery with C17-monoglycerol ester liquid crystal-forming lipid. J Oleo Sci. 2017;66(5):443.CrossRefPubMedGoogle Scholar
  17. 17.
    Yariv D, Efrat R, Libster D, et al. In vitro permeation of diclofenac salts from lyotropic liquid crystalline systems. Colloids Surf B Biointerfaces. 2010;78(2):185–92.CrossRefPubMedGoogle Scholar
  18. 18.
    Mishraki T, Libster D, Aserin A, et al. Temperature-dependent behavior of lysozyme within the reverse hexagonal mesophases (H(II)). Colloids Surf B Biointerfaces. 2010;75(2):391.CrossRefPubMedGoogle Scholar
  19. 19.
    Kim DH, Jahn A, Cho SJ, et al. Lyotropic liquid crystal systems in drug delivery: a review. J Pharmaceut Investig. 2015;45(1):1–11.CrossRefGoogle Scholar
  20. 20.
    Hitesh J, Rushikesh G, Gauri J, Jagruti M, Nirali T. Liquid crystal as accelerant in drug absorption from topical formulations. Int Res J Pharm. 2011;2(4):86–9.Google Scholar
  21. 21.
    Sekhon BS. Surfactants: pharmaceutical and medicinal aspects. J Pharm Technol Res Manag. 2013;1:11–36.CrossRefGoogle Scholar
  22. 22.
    Guo C, Wang J, Cao F, Lee RJ, Zhai G. Lyotropic liquid crystal systems in drug delivery. Drug Discov Today. 2010;15(23–24):1032–40.CrossRefPubMedGoogle Scholar
  23. 23.
    Rajabalaya R, Musa MN, Kifli N, et al. Oral and transdermal drug delivery systems: role of lipid-based lyotropic liquid crystals. Drug Des Dev Ther. 2017;11:393.CrossRefGoogle Scholar
  24. 24.
    Chen Y, Xin L, Ping M, et al. Phytantriol-Based In Situ Liquid Crystals with Long-Term Release for Intra-articular Administration. Aaps Pharmscitech. 2015;16(4):846–54.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Liu Q, Wan XX, Huang XP. A study on the relationship between the octanol/water partition coefficient and transdermal speed constant of sinomenine. J Branch Campus First Mil Med Univ. 2000;23(1):5–6.Google Scholar
  26. 26.
    Wang B, Wang YQ, Yi-Qiong PU, et al. Apparent Oil/water Partition Coefficient of 20(S)-PPD and Its Intestinal Absorption in Rats. Chin J Inf Tradit Chin Med. 2011;18(12):59–61.Google Scholar
  27. 27.
    Kaiser KLE, Valdmanis I. Apparent octanol/water partition coefficients of pentachlorophenol as. Can J Chem. 2011;60(16):2104–6.CrossRefGoogle Scholar
  28. 28.
    Mcbride EM, Kretsch A, Garibay LK, et al. Rapid experimental and computational determination of phenethylamine drug analogue lipophilicity. Forensic Chem. 2016;1:58–65.CrossRefGoogle Scholar
  29. 29.
    Carvalho FC, Campos ML, Peccinini RG, et al. Nasal administration of liquid crystal precursor mucoadhesive vehicle as an alternative antiretroviral therapy. Eur J Pharm Biopharmaceut. 2013;84(1):219.CrossRefGoogle Scholar
  30. 30.
    Borgheti-Cardoso LN, Depieri LV, Diniz H, Calzzani RA, Fantini MC, Lyomasa MM, et al. Self-assembling gelling formulation based on a crystalline-phase liquid as a non-viral vector for siRNA delivery. Eur J Pharm Sci. 2014;58(16):72–82.CrossRefPubMedGoogle Scholar
  31. 31.
    Han K, Pan X, Chen M, Wang R, Xu Y, Feng M, et al. Phytantriol-based inverted type bicontinuous cubic phase for vascular embolization and drug sustained release. Eur J Pharm Sci. 2010;41(5):692–9.CrossRefPubMedGoogle Scholar
  32. 32.
    Akbar S. Phytantriol based smart nano-carriers for drug delivery applications. Eur J Pharmaceut Sci. 2017;101:31–42.CrossRefGoogle Scholar
  33. 33.
    Suksaeree J, Nawathong N, Anakkawee R, et al. Formulation of Polyherbal Patches Based on Polyvinyl Alcohol and Hydroxypropylmethyl Cellulose: Characterization and In Vitro Evaluation. Aaps Pharmscitech. 2017:1–10.Google Scholar
  34. 34.
    Souza C, de Freitas LA, Maia Campos PM. Topical Formulation Containing Beeswax-Based Nanoparticles Improved In Vivo Skin Barrier Function. Aaps Pharmscitech. 2017:1–12.Google Scholar
  35. 35.
    And CR, Kunieda H. Effect of Electrolytes on Discontinuous Cubic Phases. Langmuir. 2000;16(22):8263–9.CrossRefGoogle Scholar
  36. 36.
    Rodriguez-Abreu C, Acharya DP, Aramaki K, et al. Structure and rheology of direct and reverse liquid-crystal phases in a block copolymer/water/oil system. Colloids Surf A Physicochem Eng Asp. 2005;269(1):59–66.CrossRefGoogle Scholar
  37. 37.
    Sato T, Hossain MK, Acharya DP, et al. Phase Behavior and Self-Organized Structures in Water/Poly(oxyethylene) Cholesteryl Ether Systems. J Phys Chem B. 2004;108(34):12927–39.CrossRefGoogle Scholar
  38. 38.
    Cohenavrahami M, Aserin A, Garti N. H(II) mesophase and peptide cell-penetrating enhancers for improved transdermal delivery of sodium diclofenac. Colloids Surf B Biointerfaces. 2010;77(2):131–8.CrossRefGoogle Scholar
  39. 39.
    Sintov AC, Botner S. Transdermal drug delivery using microemulsion and aqueous systems: influence of skin storage conditions on the in vitro permeability of diclofenac from aqueous vehicle systems. Int J Pharm. 2006;311(2):55–62.CrossRefPubMedGoogle Scholar
  40. 40.
    Guyot M, Fawaz F. Design and in vitro evaluation of adhesive matrix for transdermal delivery of propranolol. Int J Pharm. 2000;204(1–2):171–82.CrossRefPubMedGoogle Scholar
  41. 41.
    Barauskas J, Landh T. Phase behavior of the phytantriol/water system. Langmuir. 2003;19(23):9562–5.CrossRefGoogle Scholar
  42. 42.
    Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13(2):123–33.CrossRefPubMedGoogle Scholar
  43. 43.
    Réeff J, Gaignaux A, Goole J, et al. Characterization and optimization of GMO-based gels with long term release for intraarticular administration. Int J Pharm. 2013;451(1–2):95–103.CrossRefPubMedGoogle Scholar
  44. 44.
    Chaiyana W, Rades T, Okonogi S. Characterization and in vitro permeation study of microemulsions and liquid crystalline systems containing the anticholinesterase alkaloidal extract from Tabernaemontana divaricata. Int J Pharm. 2013;452(1–2):201–10.CrossRefPubMedGoogle Scholar
  45. 45.
    Efrat R, Aserin A, Garti N. On structural transitions in a discontinuous micellar cubic phase loaded with sodium diclofenac. J Colloid Interf Sci. 2008;321(1):166–76.CrossRefGoogle Scholar
  46. 46.
    Iwanaga T, Kunieda H. Effect of added salts or polyols on the cloud point and the liquid-crystalline structures of polyoxyethylene-modified silicone. J Colloid Interface Sci. 2000;227(2):349.CrossRefPubMedGoogle Scholar
  47. 47.
    Patil SS, Venugopal E, Bhat S, Mahadik KR, Paradkar AR. Mapping ion-induced mesophasic transformation in lyotropic in situ gelling system and its correlation with pharmaceutical performance. Pharm Res. 2013;30(7):1906–14.CrossRefPubMedGoogle Scholar
  48. 48.
    Phan S, Fong WK, Kirby N, Hanley T, Boyd BJ. Evaluating the link between self-assembled mesophase structure and drug release. Int J Pharm. 2011;421(1):176–82.CrossRefPubMedGoogle Scholar
  49. 49.
    Patil SS, Venugopal E, Bhat S, Mahadik KR, Paradkar AR. Exploring microstructural changes in structural analogues of ibuprofen-hosted in situ gelling system and its influence on pharmaceutical performance. AAPS PharmSciTech. 2015;16(5):1153–9.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Cao JJ, Li ZG, Li Q, et al. Preparation and evaluation of sinomenine liquid crystal gel. Chin Pharm J. 2017;52(19):1691–7.Google Scholar
  51. 51.
    Misiūnas A, Niaura G, Barauskas J, et al. Horse heart cytochrome centrapped into the hydrated liquid-crystalline phases of phytantriol: X-ray diffraction and Raman spectroscopic characterization. J Colloid Interface Sci. 2012;378(1):232–40.CrossRefPubMedGoogle Scholar
  52. 52.
    Nuki G, Ferguson J. Studies on the nature and significance of macromolecular complexes in the rheology of synovial fluid from normal and diseased human joints. Rheologica Acta. 1971;10(1):8–14.CrossRefGoogle Scholar
  53. 53.
    Ghosh I, Michniak-Kohn B. A comparative study of vitamin E TPGS/HPMC supersaturated system and other solubilizer/polymer combinations to enhance the permeability of a poorly soluble drug through the skin. Drug Dev Ind Pharm. 2012;38(11):1408.CrossRefPubMedGoogle Scholar
  54. 54.
    Latsch S, Selzer T, Fink L, et al. Crystallisation of estradiol containing TDDS determined by isothermal microcalorimetry, X-ray diffraction, and optical microscopy. Eur J Pharm Biopharm. 2003;56(1):43–52.CrossRefPubMedGoogle Scholar
  55. 55.
    Éder André E, Fabíola Silva Garcia P, Ana Beatriz C, Maria Bernadete Riemma P, Marilisa Guimarães L. Liquid crystalline systems for transdermal delivery of Celecoxib: in vitro drug release and skin permeation studies. Am Assoc Pharm Sci. 2014;15(6):1468–75.Google Scholar
  56. 56.
    Clogston J, Rathman J, Tomasko D, Walker H, Caffrey M. Phase behavior of a monoacylglycerol (Myverol 18-99K)/water system. Chem Phys Lipids. 2000;107:191–220.CrossRefPubMedGoogle Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2018

Authors and Affiliations

  • Xiaoqin Chu
    • 1
    • 2
    • 3
  • Qian Li
    • 2
  • Shuangying Gui
    • 2
    • 3
  • Zhengguang Li
    • 2
  • Jiaojiao Cao
    • 2
  • Jianqin Jiang
    • 1
    • 4
  1. 1.School of Traditional Chinese PharmacyChina Pharmaceutical UniversityNanjingChina
  2. 2.School of PharmacyAnhui University of Chinese MedicineHefeiChina
  3. 3.Institute of PharmaceuticsAnhui Academy of Chinese MedicineHefeiChina
  4. 4.Cellular and Molecular Biology CenterChina Pharmaceutical UniversityNanjingChina

Personalised recommendations